TSO3. (TOS) Price Target Lowered to C$2.00 at Canaccord Genuity

TSO3. (TSE:TOS) had its price objective lowered by Canaccord Genuity from C$2.40 to C$2.00 in a report released on Thursday morning.

TOS has been the subject of several other reports. Scotiabank decreased their price objective on shares of TSO3. from C$4.50 to C$2.75 and set an outperform rating for the company in a report on Tuesday, January 30th. Royal Bank of Canada decreased their price objective on shares of TSO3. from C$2.00 to C$1.75 and set a sector perform rating for the company in a report on Tuesday, March 13th. National Bank Financial decreased their price objective on shares of TSO3. from C$2.25 to C$1.75 and set a sector perform rating for the company in a report on Thursday, March 22nd. Finally, Desjardins decreased their price objective on shares of TSO3. from C$1.60 to C$0.90 in a report on Thursday. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The stock currently has a consensus rating of Hold and a consensus target price of C$1.73.

TSO3. stock opened at C$0.72 on Thursday. TSO3. has a 12-month low of C$0.56 and a 12-month high of C$3.30.

TSO3. (TSE:TOS) last posted its quarterly earnings data on Tuesday, March 20th. The company reported C($0.03) earnings per share (EPS) for the quarter, meeting the consensus estimate of C($0.03). The business had revenue of C$7.34 million during the quarter, compared to analysts’ expectations of C$7.31 million. TSO3. had a negative net margin of 34.69% and a negative return on equity of 48.85%.

In other TSO3. news, Director Richard Mark Rumble bought 105,900 shares of TSO3. stock in a transaction that occurred on Tuesday, March 27th. The stock was purchased at an average cost of C$0.83 per share, for a total transaction of C$87,897.00.

About TSO3.

TSO3 Inc engages in the research, development, production, maintenance, sale, and licensing of sterilization processes, related consumable supplies, and accessories for heat and moisture sensitive medical devices. Its principal product is the STERIZONE VP4 sterilizer, a dual sterilant, low temperature sterilization system that utilizes vaporized hydrogen peroxide and ozone that is marketed in Canada and the United States.

Analyst Recommendations for TSO3. (TSE:TOS)

Receive News & Ratings for TSO3. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TSO3. and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply